Literature DB >> 21572128

Accounting for genetic heterogeneity in homozygosity mapping: application to Mendelian susceptibility to mycobacterial disease.

Audrey V Grant1, Stéphanie Boisson-Dupuis, Eléonore Herquelot, Ludovic de Beaucoudrey, Orchidée Filipe-Santos, Daniel K Nolan, Jacqueline Feinberg, Anne Boland, Saleh Al-Muhsen, Ozden Sanal, Yildiz Camcioglu, Ayse Palanduz, Sara Sebnem Kilic, Jacinta Bustamante, Jean-Laurent Casanova, Laurent Abel.   

Abstract

INTRODUCTION: Genome-wide homozygosity mapping is a powerful method for locating rare recessive Mendelian mutations. However, statistical power decreases dramatically in the presence of genetic heterogeneity.
METHODS: The authors applied an empirical approach to test for linkage accounting for genetic heterogeneity by calculating the sum of positive per-family multipoint LOD scores (S) across all positions, and obtaining corresponding empirical p values (EmpP) through permutations.
RESULTS: The statistical power of the approach was found to be consistently higher than the classical heterogeneity LOD by simulations. Among 21 first-cousin matings with a single affected child, for five families linked to a locus of interest and 16 families to other loci, S/EmpP achieved a power of 40% versus 28% for heterogeneity LOD at an α level of 0.001. The mean size of peak linkage regions was markedly higher for true loci than false positive regions. The S/EmpP approach was applied to a sample of 17 consanguineous families with Mendelian susceptibility to mycobacterial disease, leading to the identification of two mutations in IL12RB1 and TYK2 from the largest of six linkage regions at p<10(-3).
CONCLUSIONS: The S/EmpP approach is a flexible and powerful approach that can be applied to linkage analysis of families with suspected Mendelian disorders.

Entities:  

Mesh:

Year:  2011        PMID: 21572128      PMCID: PMC3213022          DOI: 10.1136/jmg.2011.089128

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  18 in total

1.  Quantification of type I error probabilities for heterogeneity LOD scores.

Authors:  Paula C Abreu; Susan E Hodge; David A Greenberg
Journal:  Genet Epidemiol       Date:  2002-02       Impact factor: 2.135

2.  Merlin--rapid analysis of dense genetic maps using sparse gene flow trees.

Authors:  Gonçalo R Abecasis; Stacey S Cherny; William O Cookson; Lon R Cardon
Journal:  Nat Genet       Date:  2001-12-03       Impact factor: 38.330

3.  Efficiency and power in genetic association studies.

Authors:  Paul I W de Bakker; Roman Yelensky; Itsik Pe'er; Stacey B Gabriel; Mark J Daly; David Altshuler
Journal:  Nat Genet       Date:  2005-10-23       Impact factor: 38.330

4.  A new test for linkage in the presence of locus heterogeneity.

Authors:  C J MacLean; L M Ploughman; S R Diehl; K S Kendler
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

Review 5.  Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features.

Authors:  Orchidée Filipe-Santos; Jacinta Bustamante; Ariane Chapgier; Guillaume Vogt; Ludovic de Beaucoudrey; Jacqueline Feinberg; Emmanuelle Jouanguy; Stéphanie Boisson-Dupuis; Claire Fieschi; Capucine Picard; Jean-Laurent Casanova
Journal:  Semin Immunol       Date:  2006-09-25       Impact factor: 11.130

6.  Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.

Authors:  F Altare; A Durandy; D Lammas; J F Emile; S Lamhamedi; F Le Deist; P Drysdale; E Jouanguy; R Döffinger; F Bernaudin; O Jeppsson; J A Gollob; E Meinl; A W Segal; A Fischer; D Kumararatne; J L Casanova
Journal:  Science       Date:  1998-05-29       Impact factor: 47.728

Review 7.  Genetic dissection of immunity to mycobacteria: the human model.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

8.  Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity.

Authors:  Yoshiyuki Minegishi; Masako Saito; Tomohiro Morio; Ken Watanabe; Kazunaga Agematsu; Shigeru Tsuchiya; Hidetoshi Takada; Toshiro Hara; Nobuaki Kawamura; Tadashi Ariga; Hideo Kaneko; Naomi Kondo; Ikuya Tsuge; Akihiro Yachie; Yukio Sakiyama; Tsutomu Iwata; Fumio Bessho; Tsutomu Ohishi; Kosuke Joh; Kohsuke Imai; Kazuhiro Kogawa; Miwa Shinohara; Mikiya Fujieda; Hiroshi Wakiguchi; Srdjan Pasic; Mario Abinun; Hans D Ochs; Eleonore D Renner; Annette Jansson; Bernd H Belohradsky; Ayse Metin; Norio Shimizu; Shuki Mizutani; Toshio Miyawaki; Shigeaki Nonoyama; Hajime Karasuyama
Journal:  Immunity       Date:  2006-11       Impact factor: 31.745

9.  Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children.

Authors:  E S Lander; D Botstein
Journal:  Science       Date:  1987-06-19       Impact factor: 47.728

10.  Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications.

Authors:  Claire Fieschi; Stéphanie Dupuis; Emilie Catherinot; Jacqueline Feinberg; Jacinta Bustamante; Adrien Breiman; Frédéric Altare; Richard Baretto; Françoise Le Deist; Samer Kayal; Hartmut Koch; Darko Richter; Martin Brezina; Guzide Aksu; Phil Wood; Suliman Al-Jumaah; Miquel Raspall; Alberto José Da Silva Duarte; David Tuerlinckx; Jean-Louis Virelizier; Alain Fischer; Andrea Enright; Jutta Bernhöft; Aileen M Cleary; Christiane Vermylen; Carlos Rodriguez-Gallego; Graham Davies; Renate Blütters-Sawatzki; Claire-Anne Siegrist; Mohammad S Ehlayel; Vas Novelli; Walther H Haas; Jacob Levy; Joachim Freihorst; Sami Al-Hajjar; David Nadal; Dewton De Moraes Vasconcelos; Olle Jeppsson; Necil Kutukculer; Klara Frecerova; Isabel Caragol; David Lammas; Dinakantha S Kumararatne; Laurent Abel; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2003-02-17       Impact factor: 14.307

View more
  10 in total

1.  Microarray analysis of Mycobacterium tuberculosis-infected monocytes reveals IL26 as a new candidate gene for tuberculosis susceptibility.

Authors:  José M Guerra-Laso; Sara Raposo-García; Silvia García-García; Cristina Diez-Tascón; Octavio M Rivero-Lezcano
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

Review 2.  Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases.

Authors:  Sayna Norouzi; Asghar Aghamohammadi; Setareh Mamishi; Sergio D Rosenzweig; Nima Rezaei
Journal:  J Infect       Date:  2012-03-16       Impact factor: 6.072

Review 3.  Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.

Authors:  Jacinta Bustamante; Stéphanie Boisson-Dupuis; Laurent Abel; Jean-Laurent Casanova
Journal:  Semin Immunol       Date:  2014-10-26       Impact factor: 11.130

Review 4.  Hyperimmunoglobulin E syndromes in pediatrics.

Authors:  Qian Zhang; Helen C Su
Journal:  Curr Opin Pediatr       Date:  2011-12       Impact factor: 2.856

5.  Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency.

Authors:  Dusan Bogunovic; Minji Byun; Larissa A Durfee; Avinash Abhyankar; Ozden Sanal; Davood Mansouri; Sandra Salem; Irena Radovanovic; Audrey V Grant; Parisa Adimi; Nahal Mansouri; Satoshi Okada; Vanessa L Bryant; Xiao-Fei Kong; Alexandra Kreins; Marcela Moncada Velez; Bertrand Boisson; Soheila Khalilzadeh; Ugur Ozcelik; Ilad Alavi Darazam; John W Schoggins; Charles M Rice; Saleh Al-Muhsen; Marcel Behr; Guillaume Vogt; Anne Puel; Jacinta Bustamante; Philippe Gros; Jon M Huibregtse; Laurent Abel; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova
Journal:  Science       Date:  2012-08-02       Impact factor: 47.728

6.  Human IFN-γ immunity to mycobacteria is governed by both IL-12 and IL-23.

Authors:  Rubén Martínez-Barricarte; Janet G Markle; Cindy S Ma; Elissa K Deenick; Noé Ramírez-Alejo; Federico Mele; Daniela Latorre; Seyed Alireza Mahdaviani; Caner Aytekin; Davood Mansouri; Vanessa L Bryant; Fabienne Jabot-Hanin; Caroline Deswarte; Alejandro Nieto-Patlán; Laura Surace; Gaspard Kerner; Yuval Itan; Sandra Jovic; Danielle T Avery; Natalie Wong; Geetha Rao; Etienne Patin; Satoshi Okada; Benedetta Bigio; Bertrand Boisson; Franck Rapaport; Yoann Seeleuthner; Monika Schmidt; Aydan Ikinciogullari; Figen Dogu; Gonul Tanir; Payam Tabarsi; Mohammed Reza Bloursaz; Julia K Joseph; Avneet Heer; Xiao-Fei Kong; Mélanie Migaud; Tomi Lazarov; Frédéric Geissmann; Bernhard Fleckenstein; Cecilia Lindestam Arlehamn; Alessandro Sette; Anne Puel; Jean-François Emile; Esther van de Vosse; Lluis Quintana-Murci; James P Di Santo; Laurent Abel; Stéphanie Boisson-Dupuis; Jacinta Bustamante; Stuart G Tangye; Federica Sallusto; Jean-Laurent Casanova
Journal:  Sci Immunol       Date:  2018-12-21

7.  The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses.

Authors:  Sarah Jill de Jong; Amandine Créquer; Irina Matos; David Hum; Vignesh Gunasekharan; Lazaro Lorenzo; Fabienne Jabot-Hanin; Elias Imahorn; Andres A Arias; Hassan Vahidnezhad; Leila Youssefian; Janet G Markle; Etienne Patin; Aurelia D'Amico; Claire Q F Wang; Florian Full; Armin Ensser; Tina M Leisner; Leslie V Parise; Matthieu Bouaziz; Nataly Portilla Maya; Xavier Rueda Cadena; Bayaki Saka; Amir Hossein Saeidian; Nessa Aghazadeh; Sirous Zeinali; Peter Itin; James G Krueger; Lou Laimins; Laurent Abel; Elaine Fuchs; Jouni Uitto; Jose Luis Franco; Bettina Burger; Gérard Orth; Emmanuelle Jouanguy; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2018-08-01       Impact factor: 17.579

Review 8.  Severe COVID-19 represents an undiagnosed primary immunodeficiency in a high proportion of infected individuals.

Authors:  Paul E Gray; Adam W Bartlett; Stuart G Tangye
Journal:  Clin Transl Immunology       Date:  2022-04-17

Review 9.  Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy.

Authors:  Anna R Huppler; Shrinivas Bishu; Sarah L Gaffen
Journal:  Arthritis Res Ther       Date:  2012-07-23       Impact factor: 5.156

10.  Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome.

Authors:  Alexandra Y Kreins; Michael J Ciancanelli; Satoshi Okada; Xiao-Fei Kong; Noé Ramírez-Alejo; Sara Sebnem Kilic; Jamila El Baghdadi; Shigeaki Nonoyama; Seyed Alireza Mahdaviani; Fatima Ailal; Aziz Bousfiha; Davood Mansouri; Elma Nievas; Cindy S Ma; Geetha Rao; Andrea Bernasconi; Hye Sun Kuehn; Julie Niemela; Jennifer Stoddard; Paul Deveau; Aurelie Cobat; Safa El Azbaoui; Ayoub Sabri; Che Kang Lim; Mikael Sundin; Danielle T Avery; Rabih Halwani; Audrey V Grant; Bertrand Boisson; Dusan Bogunovic; Yuval Itan; Marcela Moncada-Velez; Ruben Martinez-Barricarte; Melanie Migaud; Caroline Deswarte; Laia Alsina; Daniel Kotlarz; Christoph Klein; Ingrid Muller-Fleckenstein; Bernhard Fleckenstein; Valerie Cormier-Daire; Stefan Rose-John; Capucine Picard; Lennart Hammarstrom; Anne Puel; Saleh Al-Muhsen; Laurent Abel; Damien Chaussabel; Sergio D Rosenzweig; Yoshiyuki Minegishi; Stuart G Tangye; Jacinta Bustamante; Jean-Laurent Casanova; Stéphanie Boisson-Dupuis
Journal:  J Exp Med       Date:  2015-08-24       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.